Bevacizumab
27 brands · 13 companies · product forms
Opportunity snapshot
Who competes here
Top companies by brand count — fragmented market (no dominant player) · leader share 19%
Price room
max/min price ratio 214.95x across 37 trusted points (Rs 1100.21-236486.52). NOTE: mixes strengths (graph prices carry no strength), so treat as indicative.
Brands & products on the market
Sample of 12 live products for Bevacizumab — each links to its own medicine page.
Regulatory alerts
Why this score
Launch attractiveness
40% supply-gap(45) + 25% price-variation(100) + 20% low-competition(64) + 15% supply-disruption(40), damped by confidence(100). Higher = more attractive, less crowded opportunity.
Market saturation
13 canonical companies and 27 brands compete (saturation pegged at 30 companies / 150 brands).
Price room
max/min price ratio 214.95x across 37 trusted points (Rs 1100.21-236486.52). NOTE: mixes strengths (graph prices carry no strength), so treat as indicative.
Regulatory risk
1 DRAP alert(s), latest 2023-09-24 incl. recall/safety.
Confidence
Full coverage.
Packaged brief for this strong opportunity?
Molecule page + company profiles + price-room analysis are the pilot package for pharma teams.
See packaged reports All 3868 molecules